Skip to content
naulon
Not checkedNot checked for notices yet.

Eradication of Stage IV Gastric Cancer: Case Report

Ibrahim Mohammed, Cherishma Nagisetty, Arslan Iqbal and 4 more

Marshall Journal of Medicine · 2020

doi:10.33470/2379-9536.1259 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Background Gastric cancer has a low overall survival rate worldwide, and surgery remains the only intent to cure option at the early stages of the disease. HER-2 positive cancers may have a survival advantage. We present a patient with stage IV gastric cancer HER-2 positive responsive to Herceptin, free of detectable disease two years after surgery. Patient Presentation Seventy years old Caucasian male complained of left-sided chest pain. Upon evaluation, he was diagnosed with HER-2 positive adenocarcinoma of the stomach at the pylorus with two liver metastases. Near complete response was observed with Herceptin and cis-platinum based chemotherapy followed by 80% distal gastrectomy and liver resection with uneventful recovery. Two years follow up reported a patient living a normal life with undetectable disease. Conclusion Multimodality targeted therapy may accomplish twenty-four months cure of advanced malignant gastric disease.

Abstract licence: CC BY-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.